|
|
|
|
LEADER |
00000cam a2200000M 4500 |
001 |
SCIDIR_on1380459335 |
003 |
OCoLC |
005 |
20231120010741.0 |
006 |
m o d |
007 |
cr |n||||||||| |
008 |
230528s2023 xx o 0|| 0 eng d |
040 |
|
|
|a YDX
|b eng
|c YDX
|d OPELS
|d UKMGB
|d OCLCF
|d OCLCO
|
015 |
|
|
|a GBC376392
|2 bnb
|
016 |
7 |
|
|a 021026812
|2 Uk
|
019 |
|
|
|a 1388633130
|
020 |
|
|
|a 9780323950589
|q (electronic bk.)
|
020 |
|
|
|a 0323950582
|q (electronic bk.)
|
020 |
|
|
|z 9780323950572
|
035 |
|
|
|a (OCoLC)1380459335
|z (OCoLC)1388633130
|
050 |
|
4 |
|a RM345
|
082 |
0 |
4 |
|a 615.72
|2 23/eng/20230605
|
245 |
0 |
0 |
|a Bioactive lipid mediators in cardiopulmonary pharmacology /
|c edited by Darryl C. Zeldin, John M. Seubert.
|
260 |
|
|
|a [S.l.] :
|b Academic Press,
|c 2023.
|
300 |
|
|
|a 1 online resource.
|
336 |
|
|
|a text
|2 rdacontent
|
337 |
|
|
|a computer
|2 rdamedia
|
338 |
|
|
|a online resource
|2 rdacarrier
|
490 |
0 |
|
|a Advances in pharmacology ;
|v v. 97
|
520 |
|
|
|a Bioactive Lipid Mediators in Cardiopulmonary Pharmacology, Volume 97 updates readers on topics surrounding Bioactive lipid mediators. These mediators are involved in a vast array of signaling pathways that regulate both physiological and pathophysiological responses. Chapters in this new release include Cyclooxygenases and Vascular Function, Cyclooxygenases and Platelet Function, Eicosanoids and Cardiomyopathies, Cytochrome P450 Bioactive Lipids in the Heart, Epoxide Hydrolase and Leukotoxin in the Heart and Lung, Role of cytochrome P450-epoxygenase and soluble epoxide hydrolase in the regulation of vascular response, Bioactive Lipids in Hypertension, Cytochrome P450 Metabolites and Angiogenesis, 20-Hydroxyeicosatetraenoic Acid and Vascular Function, and more. Other critical sections cover Cytochrome P450 Eicosanoids and the Brain, Omega-3 Oxylipids, Resolvins, Lipoxins and Inflammation, Endocannabinoids as Bioactive Metabolites, and Oxylipins and Aspirin Exacerbated Respiratory Disease.
|
650 |
|
0 |
|a Cardiopulmonary system
|x Effect of drugs on.
|
650 |
|
0 |
|a Pulmonary pharmacology.
|
650 |
|
0 |
|a Cardiovascular pharmacology.
|
650 |
|
0 |
|a Lipids
|x Therapeutic use.
|
650 |
|
6 |
|a Appareil cardiopulmonaire
|0 (CaQQLa)201-0196670
|x Effets des m�edicaments sur.
|0 (CaQQLa)000273919
|
650 |
|
6 |
|a Pharmacologie pulmonaire.
|0 (CaQQLa)201-0198800
|
650 |
|
6 |
|a Pharmacologie cardiovasculaire.
|0 (CaQQLa)201-0024886
|
650 |
|
6 |
|a Lipides
|0 (CaQQLa)201-0025366
|x Emploi en th�erapeutique.
|0 (CaQQLa)201-0373975
|
650 |
|
7 |
|a Cardiovascular pharmacology
|2 fast
|0 (OCoLC)fst00847170
|
650 |
|
7 |
|a Lipids
|x Therapeutic use
|2 fast
|0 (OCoLC)fst00999386
|
650 |
|
7 |
|a Pulmonary pharmacology
|2 fast
|0 (OCoLC)fst01083842
|
700 |
1 |
|
|a Zeldin, Darryl C.
|
700 |
1 |
|
|a Seubert, John M.
|
776 |
0 |
8 |
|i Print version:
|z 9780323950589
|
776 |
0 |
8 |
|i Print version:
|z 0323950574
|z 9780323950572
|w (OCoLC)1352796032
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/bookseries/10543589/97
|z Texto completo
|